Isocitrate dehydrogenase plays a vital role in the tricarboxylic acid (TCA) cycle, facilitating the oxidative decarboxylation of isocitrate to α-ketoglutarate while concurrently reducing NAD⁺ to NADH or NADP⁺ to NADPH, depending on the isoform involved.

Innovative isocitrate dehydrogenase activity assay products are meticulously designed for accurate measurement of isocitrate dehydrogenase activity, which is essential for researchers investigating its significant implications in metabolic regulation and disease pathology. These assays are versatile, with applications spanning cancer research and metabolic disorders, providing reliable and reproducible results. By enabling scientists to delve into the intricate roles of isocitrate dehydrogenase in both health and disease, these products empower groundbreaking discoveries that could lead to novel therapeutic strategies and a deeper understanding of metabolic processes.